To evaluate the effect of granulocyte macrophage—colony stimulating factor (GM-CSF) in patients with oral mucositis.
DATA SOURCES:
Literature was accessed through MEDLINE (1966–June 2000) and bibliographic searches.
DATA SYNTHESIS:
Published literature assessing the use of GM-CSF to treat or prevent oral mucositis was analyzed.
CONCLUSIONS:
Reports of GM-CSF improving mucositis have been published; however, because of limitations in these reports, insufficient evidence confirms the benefits of GM-CSF. These preliminary studies provide a rationale to conduct well-designed, double-blind, randomized trials to evaluate the safety and efficacy of GM-CSF in the treatment and/or prevention of oral mucositis induced by chemotherapy and/or radiotherapy.
WilkesJD. Prevention and treatment of oral mucositis following cancer chemotherapy. Semin Oncol1998; 25: 538–51.
2.
MarksJE. Mucosal protectants and their application for head and neck chemoirradiation. Curr Opin Oncol1997; 9: 267–73.
3.
KarthausMRosenthalCGanserA. Prophylaxis and treatment of chemo- and radiotherapy-induced, oral mucositis — Are there new strategies?Bone Marrow Transplant1999;24: 1095–108.
4.
HejnaMBrodowiczTZielinkskiCC. Local use of GM-CSF for severe mucositis. Eur J Cancer1999; 35 (suppl 3):S14–7.
5.
ArmitageJO. Emerging applications of recombinant human granulocyte-macrophage colony-stimulating factor. Blood1998; 92: 4491–508.
6.
WardleyAMScarffeJH. Role of granulocyte-macrophage colony-stimulating factor in chemoradiotherapy-induced oral mucositis. J Clin Oncol1996; 14: 1741–2.
7.
GordonBSpadingerAHodgesERubyEStanleyRCocciaP. Effect of granulocyte-macrophage colony-stimulating factor on oral mucositis after hematopoietic stem-cell transplantation. J Clin Oncol1994; 12: 1917–22.
8.
ChiKHChenCHChanQKChowKCChenSYYenSH. Effect of granulocyte-macrophage colony-stimulating factor on oral mucositis in head and neck cancer patients after cisplatin, fluorouracil, and leucovorin chemotherapy. J Clin Oncol1995; 13: 2620–8.
9.
RossoMBlastGCherloneERossoR. Effect of granulocyte-macrophage colony-stimulating factor on prevention of mucositis in head and neck cancer patients treated with chemo-radiotherapy. J Chemother1997; 9: 382–5.
10.
WagnerWAlfrinkMHausUMattJ. Treatment of irradiation-induced mucositis with growth factors (rhGM-CSF) in patients with head and neck cancer. Anticancer Res1999; 19: 799–804.
11.
KannanVBapsyPPAnanthaNDovalDCVaithianathanHBanumathyG. Efficacy and safety of granulocyte macrophage—colony stimulating factor (GM-CSF) on the frequency and severity of radiation mucositis in patients with head and neck carcinoma. Int J Radiat Oncol Biol Phys1997; 37: 1005–10.
12.
CarteeLPetrosWPRosnerGLGilbertCMooreSAffrontiML. Evaluation of GM-CSF mouthwash for prevention of chemotherapy-induced mucositis: A randomized, double-blind, dose-ranging study. Cytokine1995; 7: 471–7.
13.
IbrahimEZAl-MulhimFA. Effect of granulocyte-macrophage colony-stimulating factor on chemotherapy-induced oral mucositis in non-neutropenic cancer patients. Med Oncol1997; 14: 47–81.
14.
RovirosaAFerreJBieteA. Granulocyte macrophage-colony-stimulating factor mouthwashes heal oral ulcers during head and neck radiotherapy. Int J Radiat Oncol Biol Phys1998; 41: 747–54.
15.
BezCDemarosiFSardellaALodiGBertolliVGAnnaloroC. GM-CSF mouthrinses in the treatment of severe oral mucositis. A pilot study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod1999; 88: 311–5.
